Restoration of the transcription activation function to mutant p53 in human cancer cells.
The p53 tumor suppressor gene product is a sequence-specific transcription activator frequently mutated in a variety of human malignancies. Typically, tumor-derived p53 missense mutants are defective in DNA binding and this is likely to result in a failure to active p53-regulated genes. Hence, restoring function to mutant p53 represents an attractive target to develop a novel cancer chemotherapeutic agent. We now show that a small chemically modified peptide derived from p53 restores sequence-specific DNA binding to a subset of p53 mutants. Moreover, when microinjected into human colon carcinoma cells this peptide restores the transcription activation function to endogenous mutant p53 protein. This is the first example showing that a small peptide molecule can reverse the effect of several inactivating missense mutations and restore protein function.
Abarzúa
P
P
Roche Research Center, Hoffmann-LaRoche Inc, Nutley, New Jersey 07110, USA.
LoSardo
J E
JE
Gubler
M L
ML
Spathis
R
R
Lu
Y A
YA
Felix
A
A
Neri
A
A
D000595:Amino Acid Sequence; D003110:Colonic Neoplasms / Q000235:genetics; D004247:DNA / Q000378:metabolism*; D006801:Humans; D016297:Mutagenesis, Site-Directed / Q000187:drug effects; D010446:Peptide Fragments / Q000494:pharmacology*; D017354:Point Mutation / Q000235:genetics*; D015533:Transcriptional Activation / Q000187:drug effects* / Q000235:genetics; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D010446:Peptide Fragments; D016159:Tumor Suppressor Protein p53; D004247:DNA